MECP2 and atypical Rett syndrome: The gene encoding methyl CpG binding protein 2 (Mecp2) is another predicted target of miR-155, and any gain or loss in the expression of this gene over a narrow threshold level leads to neurological impairment [38, 39], such as in MECP2 duplication syndrome and Rett syndrome.